Next, lenalidomide was added (10 μM) to cocultures of healthy donor T cells and CLL cells (1:10 ratio) for 48 h in the presence of 250 ng/ml of CXCL12. Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.